Germany passes Merkel's unpopular healthcare reform

Published 11/12/2010, 06:04 AM
Updated 11/12/2010, 06:08 AM

* German parliament approves healthcare changes

* Merkel's popularity slumps due to backlash over measure

By Erik Kirschbaum

BERLIN, Nov 12 (Reuters) - The German parliament passed healthcare reform on Friday to overhaul the country's cash-strapped insurance system and plug a threatened 11-billion euro shortfall in the public health system next year.

Chancellor Angela Merkel's centre-right coalition has called the healthcare reform bill one of its most important laws this year, even though her Christian Democrats have clashed for months over details with their Free Democrat coalition partners.

Along with savings, healthcare insurance levies will be raised for employers and for the country's 72 million insured. Anger over the rising health insurance costs has contributed to a prolonged slump in polls for Merkel's coalition.

The mandatory health insurance charge now split evenly between employers and workers will rise from January to 15.5 percent of gross wages in January from 14.9 percent. Any future increases will be paid for only by employers.

The measure has been widely attacked by opposition parties, trade unions and insurers. They complain the reforms' focus was on raising levies rather than cutting costs. They also criticise that employers must pay future increases on their own.

The issue also provoked slanging matches inside Merkel's government for months, threatening unity in her coalition.

"This law will make the healthcare system better and fairer," Health Minister Philipp Roesler told parliament. "I'd have preferred bigger steps. But small steps forward are better than big steps backwards."

Frank-Walter Steinmeier, a leader of the opposition Social Democrats, said Roesler was wrecking "one of the best healthcare systems in the world".

Analysts said the healthcare reform fell short of deeper structural reforms needed and concentrated on raising revenues.

Germany's highly regarded health system covers 72 million people via state health insurance and 8.5 million via private schemes, according to health ministry data. It employs 4.3 million people and accounts for 11 percent of economic output.

On Thursday parliament approved a set of related rules that limit the power of pharmaceutical companies to set prices in Europe's biggest market, in an effort to cut costs for the health insurance system by some 2 billion euros.

The measure limits the amount that pharmaceutical firms are allowed to charge for prescription drugs. (Additional reporting by Thorsten Severin; Editing by Charles Dick)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.